Quarterly report pursuant to sections 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 69 Months Ended
Oct. 31, 2013
Oct. 31, 2012
Oct. 31, 2013
Expenses:      
Research and development $ 773,958 $ 1,180,974 $ 6,887,006
General and administrative 1,214,535 816,502 9,457,167
Loss from operations (1,988,493) (1,997,476) (16,344,173)
Other income (expense):      
Fair value of derivative liabilities in excess of proceeds     (808,590)
Adjustments to fair value of derivative liabilities     3,150,986
Loss on extinguishment of debt     (761,492)
Financing transaction costs     (210,000)
Non-cash interest expense (12,293) (27,449) (362,075)
Interest expense     (1,357)
Impairment charges     (9,000)
Net loss before income taxes (2,000,786) (2,024,925) (15,345,701)
Provision for income taxes 50,700 2,000 56,700
Net loss $ (2,051,486) $ (2,026,925) $ (15,402,401)
Basic and diluted net loss per common share (in dollars per share) $ (0.01) $ (0.02)  
Weighted average shares used in computing basic and diluted net loss per common share (in shares) 144,247,064 87,892,196